Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity and Share-Based Compensation

v3.10.0.1
Stockholders' Equity and Share-Based Compensation
9 Months Ended
Sep. 29, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stockholders' Equity and Share-Based Compensation
Stockholders’ Equity and Share-Based Compensation
Options and Restricted Stock Units
The Company had the following common stock option activity during the thirty-nine weeks ended September 29, 2018:
Granted options to purchase 554 common shares.
Exercise of 0 options to purchase common shares.
Forfeiture of 137 option to purchase common shares.
Expiration of 697 options to purchase common shares.

The following table summarizes the Company’s restricted stock unit ("RSU") activity for the thirty-nine weeks ended September 29, 2018, and details regarding the awards outstanding and exercisable at September 29, 2018 (in thousands):
 
Shares
 
Weighted
Average
Exercise Price
 
Weighted Average
Remaining
Contractual
Term (in years)
 
Aggregate
Intrinsic Value
Awards outstanding, December 30, 2017
1,113

 
$

 
 
 
 
Awarded
1,212

 
$

 
 
 
 
Vested
(497
)
 
$

 
 
 
 
Forfeited
(351
)
 
$

 
 
 
 
Awards outstanding, September 29, 2018
1,477

 
$

 
0.84
 
$
2,290

Vested and expected to vest at September 29, 2018
1,477

 
$

 
0.84
 
$
2,290

During the thirty-nine weeks ended September 29, 2018, 366 RSU's that vested were time-based and 131 were performance-based. For the RSUs awarded, the number of shares issued on the date of vest is net of the minimum statutory withholding requirements that we pay in cash to the appropriate taxing authorities on behalf of our employees. For those employees who elect not to receive shares net of the minimum statutory withholding requirements, the appropriate taxes are paid directly by the employee. During the thirty-nine weeks ended September 29, 2018, we withheld 184 shares to satisfy $430 of employees' tax obligations. Although shares withheld are not issued, they are treated as a common stock repurchase in our consolidated financial statements, as they reduce the number of shares that would have been issued upon vesting.

For the thirteen and thirty-nine weeks ended September 29, 2018, we recorded compensation costs related to stock options and RSU's of $580 and $1,739, respectively. For the thirteen and thirty-nine weeks ended September 30, 2017 we recorded compensation costs related to stock options and RSU's of $574 and $2,242, respectively. As of September 29, 2018, there was unrecognized compensation expense related to stock options and RSU's of $4,147.

Non-Controlling Interest

Non-controlling interests represent equity interests in consolidated subsidiaries that are not attributable, either directly or
indirectly, to the Company (i.e., minority interests). The Company's non-controlling interests consisted of the minority equity holders' proportionate share of the equity of AutoMD. However, during March 2017, AutoMD filed for dissolution, therefore the Company no longer has any non-controlling interests.